REPONEX PHARMACEUTICALS A/S

CVR number: 30082346
Slotsmarken 18, 2970 Hørsholm
www.reponex.dk

Income statement (kDKK)

2016
Fiscal period length12
Net sales
Gross profit241.00
Costs of management- 506.00
Costs of distribution-37.00
EBIT- 302.00
Other financial expenses- 118.00
Pre-tax profit- 420.00
Income taxes88.00
Net earnings- 332.00

Assets (kDKK)

2016
Development expenditure1 335.00
Intangible rights2 657.00
Intangible assets total3 992.00
Tangible assets total
Investments total
Long term receivables total
Raw materials and consumables487.00
Inventories total487.00
Prepayments and accrued income158.00
Current other receivables154.00
Current deferred tax assets493.00
Short term receivables total805.00
Cash and bank deposits2 658.00
Cash and cash equivalents2 658.00
Balance sheet total (assets)7 942.00

Equity and liabilities (kDKK)

2016
Share capital133.00
Share premium account6 940.00
Other reserves1 668.00
Retained earnings-3 180.00
Profit of the financial year- 332.00
Shareholders equity total5 229.00
Provisions655.00
Non-current other liabilities1 671.00
Non-current liabilities total1 671.00
Current trade creditors319.00
Other non-interest bearing current liabilities68.00
Current liabilities total387.00
Balance sheet total (liabilities)7 942.00
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.